Utilidad diagnóstica de la técnica de sangre oculta en heces en pacientes asintomáticos con enfermedades gastrointestinales

Diandra Thayri  Ferrín Zambrano; Karina Maricela  Merchán Villafuerte

doi:10.59169/pentaciencias.v6i1.952

Authors

Diandra Thayri Ferrín Zambrano Universidad Estatal del Sur de Manabí https://orcid.org/0000-0002-4219-3387
Karina Maricela Merchán Villafuerte Universidad Estatal del Sur de Manabí https://orcid.org/0000-0002-8059-7518

DOI:

https://doi.org/10.59169/pentaciencias.v6i1.952

Keywords:

Colorectal cancer, screening, fecal immunochemical test

Abstract

Gastrointestinal diseases are those that affect the digestive tract, they can manifest as non-malignant lesions that if left untreated can become precursors of cancer, therefore, in this study, the objective was to evaluate the diagnostic utility of the fecal occult blood technique in asymptomatic patients with gastrointestinal diseases, This study was carried out with the application of a documentary design methodology, using scientific databases such as PubMed, LILACS, SciELO, Dialnet, Google Scholar, reports from the Ministry of Public Health and the official website of the World Health Organization, obtaining as result that the screening programs are focused on the early discovery of occult bleeding and that most of the countries have the fecal immunochemical test as the preferred test, in which, at the time of detecting positive occult blood and follow up, polyps, advanced adenomas and colorectal cancer are frequently detected. The conclusion was that for the detection of gastrointestinal diseases, countries opt for the use of these tests for early diagnosis and it is evident that few Latin American countries have organized screening programs.

Downloads

Download data is not yet available.

References

Almansoori, A., Alzaabi, M., & Alketbi, L. (2021). Colorectal Cancer screening in ambulatory healthcare service clinics in Abu Dhabi, United Arab Emirates in 2015–2016. BMC Cancer, 21(1), 1–9. https://doi.org/10.1186/s12885-021-08623-9

Aroca Albiño, J. M., & Vélez Zamora, L. (2021). Prevalencia de Helicobacter pylori en pacientes asintomáticos en Ecuador. Revista Vive, 4(11), 193–202. https://doi.org/10.33996/revistavive.v4i11.87

Borges, L. V., Mattar, R., da Silva, J. M. K., da Silva, A. L. W., Carrilho, F. J., & Hashimoto, C. L. (2018). Fecal occult blood: A comparison of chemical and immunochemical tests. Arquivos de Gastroenterologia, 55(2), 128–132. https://doi.org/10.1590/s0004-2803.201800000-22

Bujang, N.-N.-A., Lee, Y.-J., Mohd-Zain, S.-A.-S., Aris, J.-H., Md-Yusoff, F.-A., Suli, Z., Abu-Hassan, M.-R., & Bhoo-Pathy, N. (2021). Factors Associated With Colorectal Cancer Screening Via Immunochemical Fecal Occult Blood Test in an Average-Risk Population From a Multiethnic, Middle-Income Setting. JCO Global Oncology, 7, 333–341. https://doi.org/10.1200/go.20.00460

Cheng, Y. W., & Li, Y. C. (2022). Examining the Factors That Affect the Diagnosis of Patients with Positive Fecal Occult Blood Test Results. International Journal of Environmental Research and Public Health, 19(13). https://doi.org/10.3390/ijerph19137569

Choque A, R., Gomez G, C. C., Chura H, C. A., Vargas B, S. K., Yanique C, A. G., & Magariños L, W. (2017). Determinación de sangre oculta en heces (SOH) por Inmunocromatografía en estudiantes primer año de la Facultad de Ciencias Farmacéuticas y Bioquímicas de la UMSA y su entorno familiar, en la Gestion 2016. Revista Con-Ciencia, 5(2), 81–95. http://www.scielo.org.bo/pdf/rcfb/v5n2/v5n2_a08.pdf

Concha, S., Cabalín, C., Iturriaga, C., Pérez-Mateluna, G., Gomez, C., Cifuentes, L., Harris, P. R., Gana, J. C., & Borzutzky, A. (2018). Estudio de validez diagnóstica de la prueba de hemorragia oculta fecal en lactantes con proctocolitis alérgica inducida por proteína alimentaria. Revista Chilena de Pediatria, 89(5), 630–637. https://doi.org/10.4067/S0370-41062018005000901

Costa, R., Gutiérrez, A., Valdivieso, D., Carpio, L., Cuadrado, f, & Núñez J. (2018). Vigilancia de enfermedades no transmisibles y factores de riesgo. Ministerio de Salud Pública, 2–13.

Gonzáles, L., Andrés, P., Roberti, J., Virgilio, S., Alonso, J. P., & Bardach, A. (2021). Intervenciones en ámbito laboral para incrementar el rastreo de cáncer colorrectal: evaluación de tecnología sanitaria. Revista Argentina de Salud Pública. http://rasp.msal.gov.ar/rasp/articulos/vol13/REV_Robertie52.pdf

Gupta, S. (2022). Screening for Colorectal Cancer. Hematology/Oncology Clinics of North America, 36(3), 393–414. https://doi.org/10.1016/j.hoc.2022.02.001

Gutiérrez-Stampa, M. A., Aguilar Gama, V., & Bujanda, L. (2020). Utilidad del test de sangre oculta en heces para el diagnóstico del cáncer colorrectal en la práctica clínica en atención primaria. Atencion Primaria, 52(4), 286–287. https://doi.org/10.1016/j.aprim.2019.07.009

Idigoras, I., Arrospide, A., Portillo, I., Arana-Arri, E., Martínez-Indart, L., Mar, J., De Koning, H. J., Lastra, R., Soto-Gordoa, M., Van Der Meulen, M., & Lansdorp-Vogelaar, I. (2017). Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model. BMC Public Health, 18(1). https://doi.org/10.1186/s12889-017-4639-3

Jiang, H., Zhang, P., Gu, K., & Gong, Y. (n.d.). Cost-e ectiveness analysis of a community-based colorectal cancer screening program in.

Kirschbaum, A. (2019). Test de sangre oculta en materia fecal para screening de cáncer colrrectal. In Instituto Nacional del Cáncer (Primera). http://revfinlay.sld.cu/index.php/finlay/article/view/920

Lué, A., Hijos, G., Sostres, C., Perales, A., Navarro, M., Barra, M., Mascialino, B., Andalucia, C., Puente, J., Lanas, Á., & Omollon, F. (2020). The combination of quantitative faecal occult blood test and faecal calprotectin is a cost-effective strategy to avoid colonoscopies in symptomatic patients without relevant pathology. Therapeutic Advances in Gastroenterology, 13, 1–15. https://doi.org/10.1177/1756284820920786.

Martín Alvarez, I., Rodríguez Rodríguez, L., García Acosta, I., Hernández Morejón, D., & Melians Abreu, S. M. (2016). Sangre oculta en heces fecales: un valioso auxiliar en el diagnóstico precoz del cáncer colorrectal. Revista de Ciencias Médicas de Pinar Del Río, 20(3), 312–317.

Meklin, J., Syrjänen, K., & Eskelinen, M. (2020). Fecal occult blood tests in colorectal cancer screening: Systematic review and meta-analysis of traditional and new-generation fecal immunochemical tests. Anticancer Research, 40(7), 3591–3604. https://doi.org/10.21873/ANTICANRES.14349

Nicholson, B. D., James, T., East, J. E., Grimshaw, D., Paddon, M., Justice, S., Oke, J. L., & Shine, B. (2019). Experience of adopting faecal immunochemical testing to meet the NICE colorectal cancer referral criteria for low-risk symptomatic primary care patients in Oxfordshire, UK. Frontline Gastroenterology, 10(4), 347–355. https://doi.org/10.1136/flgastro-2018-101052

OPS, & Organización Panamericana de la Salud. (2016). Consulta a Expertos sobre Tamizaje del cáncer colorrectal en América Latina y el Caribe. 1–24.

Pallesen, A. V. J., Herrstedt, J., Westendorp, R. G. J., Mortensen, L. H., & Kristiansen, M. (2021). Differential effects of colorectal cancer screening across sociodemographic groups in Denmark: a register-based study. Acta Oncologica, 60(3), 323–332. https://doi.org/10.1080/0284186X.2020.1869829

Peery, A. F., Crockett, S. D., Murphy, C. C., Jennifer, L., Dellon, E. S., Williams, J. L., Elizabeth, T., Shaheen, N. J., Barritt, A. S., Sarah, R., Kochar, B., Barnes, E. L., & Fan, Y. C. (2019). Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018. Gastroenterology, 156(1), 254–272. https://doi.org/10.1053/j.gastro.2018.08.063.Burden

Pellat, A., Deyra, J., Husson, M., Benamouzig, R., Coriat, R., & Chaussade, S. (2021). Colorectal cancer screening programme: is the French faecal immunological test (FIT) threshold optimal? Therapeutic Advances in Gastroenterology, 14, 1–8. https://doi.org/10.1177/17562848211009716

Pereyra, L., Galvarini, M., Omodeo, M., Gómez, E., Mella, J., Luna, P., & Cimmino, D. (2020). Estudio prospectivo acerca de la precisión diagn´óstica del test inmunológico de sangre oculta en materia fecal en una única ronda para la realización de pesquisa del cáncer colorrectal en pacientes de riesgo promedio en la Argentina. Revista Argentina de Coloproctología, 31(4), 116–123. https://doi.org/10.46768/racp.v0i0.64

Ramírez López, L. X., Monroy Diaz, Á. L., Limas Solano, L. M., Rincón Orozco, B., & Contador Saavedra, K. D. (2020). Técnicas de diagnóstico para detección de sangre oculta en heces como biomarcador de cáncer colorrectal. Revista Ciencia y Salud, 12(2), 102–112. https://doi.org/https://doi.org/ 10.22519/21455333.1447

Rejaibi S, Mahfoudh Mchirgui R, Ben Mansour N, Barbouch F, Kaddour N, Mrabet A, A.-S. H. (2021). Colorectal cancer mass screening, Tunisia 2019. Evaluation of a pilot program in the Tunis region (Tunisia, 2019). Tunis Med.

Ruiz, E. F., & Hasdeu, S. (2021). Rastreo de cáncer colorrectal: análisis de resultados en la provincia de Nauquén, Argentina, 2015-2019. Revista Argentina de Salud Pública, 13(38).

Sguiglia, S. (2021). Recomendación a favor de adelantar la edad de inicio del tamizaje del cáncer de colon en los EE. UU. Evid Actual Pract Ambul, 24. https://doi.org/10.51987/EVIDENCIA.V24I3.6954

SOLCA. (2019). Sociedad de Lucha Contra el Cáncer del Ecuador (SOLCA). http://www.solca.med.ec/

Suh, M., Song, S., Cho, H. N., Park, B., Jun, J. K., Choi, E., Kim, Y., & Choi, K. S. (2017). Trends in participation rates for the National Cancer Screening Program in Korea, 2002-2012. Cancer Research and Treatment, 49(3), 798–806. https://doi.org/10.4143/crt.2016.186

Tanaka, K., Sobue, T., Zha, L., Kitamura, T., Sawada, N., Iwasaki, M., Inoue, M., Yamaji, T., & Tsugane, S. (2021). Effectiveness of Screening Using Fecal Occult Blood Testing and Colonoscopy on the Risk of Colorectal Cancer: The Japan Public Health Center-based Prospective Study. Journal of Epidemiology, January 1990, 1–10. https://doi.org/10.2188/jea.je20210057

Vallejo Valdivieso, P. A., Zambrano Pincay, G. H., Vallejo Valdivieso, N. K., Vallejo Pilligua, P. Y., Bravo Cedeño, J. E., Bravo Cedeño, G. M., & Vallejo Valdivieso, L. A. (2019). Generalidades morfofisiológicas del aparato digestivo y su importancia en la homeostasia del organismo humano. In Bases morfofisiopatológicas del aparato digestivo (1ra ed.). Area de innovación y desarrollo. S.L. http://dx.doi.org/10.17993/Med.2019.68

Vilares, M. P., Iborra, O. M., Pérez, C. I., Pellisé, U. M., De Lacy Fortuny, A. M., & Balaguer, P. F. (2019). Impacto de un programa de cribado poblacional basado en detección de sangre oculta en heces sobre el manejo quirúrgico del cáncer colorrectal. Index Enferm, 28, 115–119. http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1132-12962019000200005&lng=es.

Vitellius, C., Laly, M., Banaszuk, A., Deherce, I., Cornet, N., Bertrais, S., Saulnier, P., & Caroli-Bosc, F. (2019). Contribution of the OC Sensor® immunoassay in comparison to the Hemoccult II® guaiac-test in organized colorectal cancer screening. Eur J Epidemiol., 34, 163–172. https://doi.org/10.1007/s10654-018-0471-z

Wielandt, A. M., Hurtado, C., Moreno, M., Zárate, A., & López-Köstner, F. (2021). Test de sangre oculta en deposiciones para programas de cribado de cáncer colorrectal: actualización. Revista Médica de Chile, 149(4), 580–590. https://doi.org/10.4067/s0034-98872021000400580